Tomer Kariv

Portfolio · 1

Otic Pharma

Foam-based Products for the Treatment of Ear, Nose, and Throat Disorders

1 round Latest: 2015-05

Investment activity

1 portfolio exit on record.

Q&A

What is Tomer Kariv's primary investment focus by sector?

Tomer Kariv primarily focuses on the Health Tech & Life Sciences sector, with all recorded portfolio companies and exits falling within this area.

Can you name a notable exit for Tomer Kariv?

Tomer Kariv had a notable exit in May 2017 with Otic Pharma, which was acquired by Novus Therapeutics for $7 million.

Which company is a key part of Tomer Kariv's portfolio?

Otic Pharma, a company focused on foam-based products for ENT disorders, is a key part of Tomer Kariv's portfolio. It was acquired in May 2017.

When did Tomer Kariv make their most recent recorded investment?

Tomer Kariv's most recent recorded investment was in May 2015.

What type of funding rounds has Tomer Kariv participated in?

Tomer Kariv has participated in B Round funding stages, with one such investment recorded.